The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial. [electronic resource]
Producer: 20120814Description: 1694-706 p. digitalISSN:- 1475-2662
- Adult
- Aged
- Carbohydrate Metabolism, Inborn Errors -- etiology
- Cardiovascular Diseases -- epidemiology
- Diet, Fat-Restricted
- Double-Blind Method
- Female
- Fermentation
- Germany -- epidemiology
- Glycerol Kinase -- deficiency
- Humans
- Hyperglycemia -- etiology
- Hypertension -- etiology
- Hypoadrenocorticism, Familial
- Hypolipidemic Agents -- adverse effects
- Male
- Metabolic Syndrome -- blood
- Middle Aged
- Milk Proteins -- adverse effects
- Risk Factors
- Triglycerides -- blood
- Whey Proteins
- Yogurt -- adverse effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.